EHMT2 and acute lymphoblastic leukemia: The first study carried out in this regard demonstrated that inhibition of G9a (with BIX01294) reduced the ability of infant ALL cells to migrate through an endothelial monolayer, an essential function for leukemia to progress and migrate to other tissues.